Answers are grounded in this paper and cite their sources.
We describe an approach for the efficient development of targeted isotope labeling protocols leading to nuclear magnetic resonance (NMR) structural studies of bacterial membrane proteins in intact cells and native outer membrane (OM) vesicles (OMVs). The assay relies on the bioorthogonal non-canonical amino acid tagging (BONCAT) approach for metabolic incorporation of an azide-bearing residue, followed by copper-catalyzed azide-alkyne cycloaddition (CuAAC) to an alkyne-functionalized fluorescent dye. Fluorescence detection in SDS-PAGE provides a rapid way to test samples for off-target background signal from endogenous proteins, bypassing the need for intensive NMR screening experiments. Using this approach, we develop an optimized protocol that enables high-resolution NMR spectra to be obtained in situ with negligible background signal. The BONCAT approach also enables target-specific fluorescence or nano-gold labeling of proteins at the OM surface, further extending the utility of this protocol for correlative structure-activity studies of membrane proteins in situ.
No takes yet. Share an insight, caveat, or question.
Wood et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: